1. be useful in diseases which is a public health problem in India 2. be licensed/ approved Drugs Controller General (India) (DCGI) 3. have proven efficacy and safety profile based on scientific evidence 4. be comparatively cost effective ...
Indian corporations and innovators are no longer subject to restrictions nor do they need to obtain prior approval before collecting, generating, preparing, disseminating, storing, publishing, or updating digital geospatial data and maps inside the boundaries of India.Indian Policy Current Affairs - Octo...
in May 2020 has initiated phase 3 clinical trials on antiviral favipiravir for which it received approval from India’s drug regulator DCGI in late April 2020, estimated to be completed by July/August 2020 [18]. Lopinavir and ritonavir, approved anti-HIV drugs, have been found to possess ...
2. be licensed/ approved Drugs Controller General (India) (DCGI) 3. have proven efficacy and safety profile based on scientific evidence 4. be comparatively cost effective 5. be aligned with the current treatment guidelines 6. recommended under National Health Programs of India. (e.g. Ivermectin...
1). Figur(FeRige1ud.reoAf1nC. Aohivnoegorgvvieaier,vwpieawonnelostnhAtehaemnmdaianBin)c; uc"ulVtlitavivraiaettgeeaddtobbiidooittyyCppaesestseoloffrfIatnIatclaioal"ina(nRVaaRdraiicedcgihacitcoeh:di"ooR:fo"sCsRaoostdsesilfoCrahdniicoogC,ghCiaio)";ggia" (Red"oRfosCsohidoigVgiear,onpaa...